Patients with the TRAF6 risk haplotype 2 had lower AF suPAR concentrations as compared to other haplotypes (Fig. 3A) indicating a reduced peritoneal immune activation under non-inflammatory conditions in these patients. Here, TRAF6 is linked to atrial fibrillation.